Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
Application Note
Product Sheet
Article
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Beyond the Bottleneck: Engineering Sensitive Bespoke MRD Assays
In this roundtable hosted by The Scientist, experts from BloodPAC, Stanford University, and Twist Bioscience unpack the state of tumor-informed MRD research on where the field has landed, what's holding it back, and where it's heading next.
Presented by
Shawn Gorda
Director, NGS Product Management, Twist Bioscience
Lauren Leiman
Executive Director, BLOODPAC
Ash Alizadeh, MD, PhD
MoghadamFamily Professor of Medicine, Division of Oncology, Stanford University
Covered in this Webinar
Why turnaround time has become the variable that determines whether tumor- informed MRD is viable at all and what purpose-built enrichment chemistry changes about that equation
How hybrid-capture approaches are outperforming amplicon-based strategies for high-sensitivity, personalized MRD applications — and what that means for labs building programs at scale
Where the field is expanding next, from pediatric cancers to glioblastoma, and how to build the workflow infrastructure to be ready when the evidence base arrives
This Product is currently in development and is presented for informational purposes only. Nothing herein constitutes a commitment to deliver any described product, feature, or functionality; we reserve the right to modify or discontinue development at any time without notice. Twist products are for research use only. They are not intended for the diagnosis, prevention, monitoring, or treatment of a disease or condition. Twist Bioscience assumes no liability regarding the use of our products in unintended applications.
Share your details to Watch the Webinar
